FLUTAMIDE 250 MG
FLUTAMIDE : 250 MG · DIN 02059673 · SCHERING-PLOUGH CANADA INC
Health Canada status: CANCELLED POST MARKET
What is FLUTAMIDE?
FLUTAMIDE 250 MG contains FLUTAMIDE : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02059673, held by SCHERING-PLOUGH CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Jul-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02059673 |
|---|---|
| Brand name | FLUTAMIDE |
| Generic / active ingredient | FLUTAMIDE : 250 MG |
| Manufacturer | SCHERING-PLOUGH CANADA INC |
| Strength | 250 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | L02BB01 FLUTAMIDE |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-Jul-2014 |
| Original market date | 1996-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code L02BB01 FLUTAMIDE. 1 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLUTAMIDE | 250 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02238560 |
| DOM-FLUTAMIDE | 250 MG | TABLET | DOMINION PHARMACAL | CANCELLED PRE MARKET | DIN 02230524 |
| EUFLEX | 250 MG | TABLET | MERCK CANADA INC | CANCELLED POST MARKET | DIN 00637726 |
| FLUTAMIDE | 250 MG | TABLET | PHARMEL INC | CANCELLED POST MARKET | DIN 02239045 |
| FLUTAMIDE | 250 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02230875 |
| FLUTAMIDE-250 | 250 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02239388 |
| NU-FLUTAMIDE TABLETS | 250 MG | TABLET | NU-PHARM INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02239082 |
| PENTA-FLUTAMIDE | 250 MG | TABLET | PENTAPHARM LTD. | CANCELLED (UNRETURNED ANNUAL) | DIN 02233019 |
| PMS-FLUTAMIDE | 250 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02230104 |
| TEVA-FLUTAMIDE | 250 MG | TABLET | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02230089 |
Who else supplies FLUTAMIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLUTAMIDE appears in 8 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.